Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

contra7 Aug. 30 at 11:38 PM

$SBFM ⏱️ https://www.stocktitan.net/sec-filings/SBFM/8-k-sunshine-biopharma-inc-reports-material-event-0ed2f1d693d0.html

0 · Reply

Jahubba Aug. 30 at 5:57 AM

$SBFM No one has brought up the potential cure for cancer of lung, liver and pancreas could be worth billions along with all the generics. This could potentially be worth billions. Other pharma companies are worth 30 to 300 billion. SBFM has that potential. For sure they have screwed over investors and im one of them. But maybe it will turn around now finally?

2 · Reply

WhoYOU Aug. 30 at 5:32 AM

$SBFM Why does @contra7 post on only this stock for the last few years and nothing else? Just curious he must own like 100% of the shares by now..... Hey Contra are you really Steve "slithering" SLilathy in disguise? Fair question and we need to know since your the only BULL here non stop even with horrible news and a 99% loss of investor money and confidence you are the only one still thinking a buyout is coming?

2 · Reply

Suomalainen Aug. 29 at 1:04 PM

$SBFM https://dilutiontracker.com/app/search/SBFM#:~:text=Remaining%20Warrants%20Outstanding,Sign%20up%20to%20view&text=Exercise%20Price,%2420.00&text=Total%20Warrants%20Issued,1%2C751&text=Known%20Owners,Sign%20up%20to%20view&text=Underwriter%2FPlacement%20agent

0 · Reply

FatCatFenix Aug. 28 at 11:14 PM

$SBFM Ohhh Mannn!!!! Can’t say I didn’t warn y’all!!! @contra7 How’s that buyout looking 😂 August 28th 2026. Sunshine Biopharma Inc. is offering 25,477,133 shares of common stock. The shares are issuable upon exercise of outstanding Series B Warrants which were issued in our public offering that closed on February 15, 2024, have a current exercise price of $1.2202, and expire February 15, 2029. The number of shares underlying the Series B Warrants and exercise price are subject to further adjustment. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=320316830&type=HTML&symbol=SBFM&cdn=618f2d732af95210d39c35281e6469a4&companyName=Sunshine+Biopharma+Inc.&formType=S-1&formDescription=Registration+statement+under+Securities+Act+of+1933&dateFiled=2026-08-28

1 · Reply

hotslots Aug. 28 at 9:59 PM

$SBFM all part of the master plan to enrich us all

0 · Reply

FatCatFenix Aug. 28 at 1:51 PM

$SBFM Funny how the volume dried up so quickly, not much of it was retail. If you’re wondering, it was dilutive warrants and the offering… with much more on the horizon. Don’t get caught up in fluff filled rehashed PR’s created yearly to bring in a new hoard of bag holders. History ALWAYS repeats itself here.

0 · Reply

TraderQ100 Aug. 28 at 11:56 AM

$MI same investors from the 13Gs ran $ZCMD $SBFM $CIIT and several more.

0 · Reply

MarketManStockWizzard Aug. 28 at 11:23 AM

$JAGX @ flatrock200 $SBFM Sunshine Biopharma entered into an at-the-market (ATM) sales agreement on July 20, 2026, to sell up to $4 million of common stock through Aegis Capital using an existing shelf registration statement. And $JAGX doing a $40M offering... BOL!

1 · Reply

flatrock100 Aug. 28 at 10:23 AM

$SBFM $JAGX nxt wk should pop

1 · Reply

Sunshine Biopharma files to sell 24.48M shares of common stock

2026-08-26T13:35:58.000Z - 4 days ago

Sunshine Biopharma provides update, outlines plans for oncology project

Aug 26, 2026, 9:00 AM EDT - 4 days ago

Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer

2026-08-19T13:11:16.000Z - 11 days ago

Sunshine Biopharma receives Canadian regulatory approval for Enalapril

Aug 19, 2026, 9:00 AM EDT - 11 days ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

2026-08-07T13:06:38.000Z - 23 days ago

Sunshine Biopharma launches generic amoxicillin formulation in Canada

Aug 7, 2026, 9:00 AM EDT - 23 days ago

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

2026-08-04T13:16:02.000Z - 26 days ago

Sunshine announces approval of generic Dienogest tablets for Canadian market

Aug 4, 2026, 9:00 AM EDT - 26 days ago

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

2026-07-28T12:21:42.000Z - 4 weeks ago

Sunshine Biopharma announces approval of generic Ondansetron tablets

Jul 28, 2026, 8:00 AM EDT - 4 weeks ago

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

2026-07-20T12:45:19.000Z - 5 weeks ago

Sunshine Biopharma announces publication of new results on MR1-114

Jul 20, 2026, 8:30 AM EDT - 5 weeks ago

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

2026-06-25T12:20:47.000Z - 2 months ago

Sunshine Biopharma receives Canadian approval for generic Arimidex

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

2026-06-01T12:23:56.000Z - 3 months ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

2026-05-29T23:55:22.000Z - 3 months ago

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T13:11:09.000Z - 3 months ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

May 29, 2026, 8:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

2026-05-28T14:49:55.000Z - 3 months ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

May 28, 2026, 9:00 AM EDT - 3 months ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

2026-05-21T11:17:11.000Z - 3 months ago

Sunshine announces approval of generic amoxicillin formulation for Canada

May 21, 2026, 7:00 AM EDT - 3 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

2026-05-19T16:21:43.000Z - 3 months ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

May 19, 2026, 12:05 PM EDT - 3 months ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 3 months ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

2026-05-18T12:55:34.000Z - 3 months ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-12T21:20:04.000Z - 3 months ago

Sunshine Biopharma files to sell 5.825M common units

2026-04-06T12:53:12.000Z - 5 months ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

Apr 6, 2026, 8:30 AM EDT - 5 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 10 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 20, 2025, 7:45 AM EDT - 11 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025, 7:45 AM EDT - 11 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 11 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 11 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 7:00 AM EDT - 11 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025, 8:00 AM EDT - 11 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 3 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

contra7 Aug. 30 at 11:38 PM

$SBFM ⏱️ https://www.stocktitan.net/sec-filings/SBFM/8-k-sunshine-biopharma-inc-reports-material-event-0ed2f1d693d0.html

0 · Reply

Jahubba Aug. 30 at 5:57 AM

2 · Reply

WhoYOU Aug. 30 at 5:32 AM

2 · Reply

Suomalainen Aug. 29 at 1:04 PM

0 · Reply

FatCatFenix Aug. 28 at 11:14 PM

1 · Reply

hotslots Aug. 28 at 9:59 PM

$SBFM all part of the master plan to enrich us all

0 · Reply

FatCatFenix Aug. 28 at 1:51 PM

0 · Reply

TraderQ100 Aug. 28 at 11:56 AM

$MI same investors from the 13Gs ran $ZCMD $SBFM $CIIT and several more.

0 · Reply

MarketManStockWizzard Aug. 28 at 11:23 AM

1 · Reply

flatrock100 Aug. 28 at 10:23 AM

$SBFM $JAGX nxt wk should pop

1 · Reply

flatrock100 Aug. 28 at 8:50 AM

$SBFM close pop

0 · Reply

Masterrunner Aug. 27 at 9:43 PM

$SBFM This is all you need to know about this shit show. It's right there; that's how much they diluted this stock and fleeced & recycled 10000s of investors🤣🤣🤣. NFA GLTY

0 · Reply

Nuisance Aug. 27 at 7:57 PM

$SBFM https://www.globenewswire.com/news-release/2026/08/26/3351434/0/en/a-multibillion-dollar-mrna-cancer-market-is-taking-shape-targeting-lung-cancer-s-biggest-opportunity.html

0 · Reply

Nuisance Aug. 27 at 7:54 PM

$SBFM 🔥🔥🔥 https://finance.yahoo.com/healthcare/articles/sunshine-biopharma-reports-vivo-tumor-130000376.html

0 · Reply

bhkk Aug. 27 at 6:18 PM

$SBFM ppl loading heavily.....will jump big soon

1 · Reply

Nuisance Aug. 27 at 5:47 PM

$SBFM Something 🔥🔥🔥

0 · Reply

Swagger_Ape Aug. 27 at 5:18 PM

$SBFM $VMAR Keep eyes on ticker AAME. AAME about to breakout massive here! Small float! Best to be early on these type of plays, they can take off fast!!1

0 · Reply

bhkk Aug. 27 at 5:08 PM

$SBFM movinh...near day highs

0 · Reply

bhkk Aug. 27 at 4:21 PM

$SBFM going to $1.7 today or tomorrow..

0 · Reply

djgestates Aug. 27 at 3:42 PM

$SBFM What I find fascinating (and it is not the SEC or FINRA's refusal for broader protections . . . I long gave up on that), but the ease with which we can access information through Gemini, Claude, Chat, etc. Yet retail traders continue to get caught up with these scams. I wish I had Gemini when I got into $SBFM (yes, it's been over three years). Steep learning curve.

2 · Reply

FatCatFenix Aug. 27 at 12:39 PM

$SBFM Will all come crashing down as always… over 30M shares from the ATM and Warrants just waiting to dilute.

0 · Reply

Nuisance Aug. 27 at 12:28 PM

$SBFM good premarket Volume 📈

0 · Reply

Market Cap	4.46M
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	451,700
Avg Vol	618,392
Day's Range	N/A - N/A
Shares Out	3.88M
Stochastic %K	47%
Beta	1.16
Analysts	Sell
Price Target	$56.00